Transcriptomics

Dataset Information

0

Impact of elraglusib (9-ING-41) treatment on gene expression in human colorectal cancer and immune cell lines.


ABSTRACT: A growing body of literature evaluates the potential anti-cancer and immunostimulatory effects of GSK-3 inhibition. Accordingly, we sought to evaluate GSK-3 inhibitor elraglusib (9-ING-41) and its impact on gene expression in both human colorectal cancer (CRC) cell lines and human immune cell lines. We used microarrays to detail the differential gene expression that occurs post-treatment with GSK-3 inhibitor 9-ING-41 (elraglusib).

ORGANISM(S): Homo sapiens

PROVIDER: GSE222849 | GEO | 2023/02/16

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

| 2284734 | ecrin-mdr-crc
2021-10-31 | GSE184125 | GEO
| PRJNA763229 | ENA
2024-07-02 | GSE230584 | GEO
2024-07-02 | GSE230589 | GEO
2024-07-02 | GSE230588 | GEO
2024-07-02 | GSE230590 | GEO
2010-05-26 | E-GEOD-10569 | biostudies-arrayexpress
2008-02-28 | GSE10569 | GEO
2018-04-25 | GSE106814 | GEO